ObesityWeek 2025: Breakthrough Results Reshaping the Obesity Market Landscape | DelveInsight

ObesityWeek 2025, held in Atlanta from November 4-7, showcased unprecedented clinical data that signals a fundamental shift in the obesity treatment landscape. The most striking breakthrough at ObesityWeek 2025 came from next-generation combination therapies and innovative approaches addressing treatment limitations that have plagued earlier interventions. LAS VEGAS, Nov. 13, 2025 /PRNewswire/ — The annual conference presented over 100 scientific sessions featuring innovations from leading pharmaceutical companies, including Novo Nordisk, Eli Lilly and Company, Viking Therapeutics, Ascletis Pharma, Skye Bioscience, Palatin Technologies, Inc., Neurogastrx, Inc., OrsoBio, Metsera, and others, revealing not only significant advances in drug efficacy but also reshaping the…